Business

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYONCLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced it received expanded 510(k) clearance from the U.S. Food and Drug Administration (the “FDA”) for

articleApyx Medical CorporationMay 11, 20265/company/apyx-medical-inc/news/apyx-medical-corporation-receives-expanded-fda-510k-clearance-adding-power-liposuction-capability-to-ayon-body-contouring-systemtm
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

About this update from Apyx Medical Corporation

[{"type":"image","alt":"Apyx Medical Corporation","displaySize":"","headline":null,"caption":"Apyx Medical Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":157,"url":"https://media.zenfs.com/en/globenewswire.com/f776ee7f25241f6a4c93b21ba8aff893"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/U9yM5iaSKXMSmeZr1pGouA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMA--/https://media.zenfs.com/en/globenewswire.com/f776ee7f25241f6a4c93b21ba8aff893","width":300,"height":157},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/U9yM5iaSKXMSmeZr1pGouA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMA--/https://media.zenfs.com/en/globenewswire.com/f776ee7f25241f6a4c93b21ba8aff893","width":300,"height":157}},"lazy":false},{"type":"text","content":"Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON","length":143,"tagName":"p"},{"type":"text","content":"CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced it received expanded 510(k) clearance from the U.S. Food and Drug Administration (the “FDA”) for the AYON Body Contouring System (“AYON”) to include power liposuction, an advanced form of liposuction that uses a reciprocating cannula to enhance efficiency of fat removal to reduce a surgeon’s effort and operating room time.","length":584,"tagName":"p"},{"type":"text","content":"“With the addition of our advanced power liposuction function, we believe AYON is the gold-standard system in surgical aesthetics. We look forward to building on this success by kicking off a limited commercial launch of the power liposuction function. This will allow our team to work closely with early adopters to refine training, utilization, and the overall customer experience before scaling commercial adoption for power liposuction,” said Charlie Goodwin, President and CEO of Apyx Medical Corporation. “By integrating power liposuction into a single, unified platform, we are enabling surgeons to perform multiple critical body contouring modalities within one system—streamlining workflow, improving procedural efficiency, and supporting optimal patient outcomes.”...

More updates from Apyx Medical Corporation

Body Contouringthe CompanyAYONApyx Medical CorporationCompanyliposuctionApyx Medical